GENT.OL
Price:
$39.4
Market Cap:
$609.07M
Gentian Diagnostics ASA develops, manufactures, and sells biochemical reagents for use in medical diagnostics and research in the United States, Asia, and Europe. It offers in-vitro diagnostic reagents for clinical chemistry analyzers, such as Gentian Calprotectin Immunoassay, a turbidimetric assay used for the measurement of circulating calprotectin in plasma and serum for detection and assessment of inflammation; Gentian Cystatin C Immunoassay test kit, a GFR marker for the diagnosis and therapeutic control of renal function and chronic kidney disease; Gentian Retinol-Binding Protein Immunoassay for detection of retinol-binding protein in human serum and plasma; and Canine CRP Immunoassay ...[Read more]
Industry
Medical - Specialties
IPO Date
2016-12-14
Stock Exchange
OSL
Ticker
GENT.OL
According to Gentian Diagnostics AS’s latest financial reports and current stock price. The company's current PE Ratio is -53.58. This represents a change of -251.29% compared to the average of 35.42 of the last 4 quarters.
The mean historical PE Ratio of Gentian Diagnostics AS over the last ten years is -27.60. The current -53.58 PE Ratio has changed 19.31% with respect to the historical average. Over the past ten years (40 quarters), GENT.OL's PE Ratio was at its highest in in the June 2017 quarter at 382.65. The PE Ratio was at its lowest in in the September 2018 quarter at -387.37.
Average
-27.60
Median
-42.19
Minimum
-66.25
Maximum
65.58
Discovering the peaks and valleys of Gentian Diagnostics AS PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 391.86%
Maximum Annual PE Ratio = 65.58
Minimum Annual Increase = -122.17%
Minimum Annual PE Ratio = -66.25
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 65.58 | 391.86% |
| 2024 | 13.33 | -122.17% |
| 2023 | -60.14 | 128.84% |
| 2022 | -26.28 | -41.23% |
| 2021 | -44.72 | -8.92% |
| 2020 | -49.10 | 103.79% |
| 2019 | -24.09 | -45.47% |
| 2018 | -44.19 | 9.96% |
| 2017 | -40.19 | -39.34% |
| 2016 | -66.25 | -26.11% |
The current PE Ratio of Gentian Diagnostics AS (GENT.OL) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
6.26
5-year avg
-10.45
10-year avg
-27.60
Gentian Diagnostics AS’s PE Ratio is less than Hofseth BioCare ASA (-4.03), less than Nykode Therapeutics AS (-6.10), less than Navamedic ASA (-14.35), less than Lifecare AS (-0.07), less than Lytix Biopharma AS (-6.46), less than ContextVision AB (publ) (25.15), less than Thor Medical ASA (-20.43), less than CodeLab Capital AS (-6.47), less than Arctic Bioscience AS (-1.85), less than BerGenBio ASA (-1.61),
| Company | PE Ratio | Market cap |
|---|---|---|
| -4.03 | $552.79M | |
| -6.10 | $1.29B | |
| -14.35 | $332.14M | |
| -0.07 | $5.40M | |
| -6.46 | $645.96M | |
| 25.15 | $318.16M | |
| -20.43 | $1.69B | |
| -6.47 | $79.02M | |
| -1.85 | $74.13M | |
| -1.61 | $45.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Gentian Diagnostics AS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Gentian Diagnostics AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Gentian Diagnostics AS's PE Ratio?
How is the PE Ratio calculated for Gentian Diagnostics AS (GENT.OL)?
What is the highest PE Ratio for Gentian Diagnostics AS (GENT.OL)?
What is the 3-year average PE Ratio for Gentian Diagnostics AS (GENT.OL)?
What is the 5-year average PE Ratio for Gentian Diagnostics AS (GENT.OL)?
How does the current PE Ratio for Gentian Diagnostics AS (GENT.OL) compare to its historical average?